Recruiting
A Study of LY3451838 in Participants With Migraine
J1H-MC-LAJB - ClinicalTrials.gov - NCT04498910
The reason for this study is to see if the study drug LY3451838 is safe and effective in participants who have migraine that have not responded to other preventive treatments.
How long will I be in the trial?
This study may last up to 10 months and may include up to 11 visits.
Recruiting
A Study of LY3451838 in Participants With Migraine
J1H-MC-LAJB - ClinicalTrials.gov - NCT04498910
The reason for this study is to see if the study drug LY3451838 is safe and effective in participants who have migraine that have not responded to other preventive treatments.
How long will I be in the trial?
This study may last up to 10 months and may include up to 11 visits.
Key Requirements
Age :
18-75
Sex:
All
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18-75
Sex
All
Participants must
Participants must have a diagnosis of migraine or chronic migraine
Participants must have a history of migraine headaches at least 1 year prior to screening and that began prior to age 50
Participants must have failed previous migraine preventive medications in the past 10 years due to too little helpfulness or the ability to put up with the medication
Participants must NOT
Participants must not be currently enrolled in or have participated within the last 30 days or within 5 half-lives (whichever is longer) in a clinical trial involving an investigational product. A half-life is the time necessary for half of any drug in the body to be removed by natural processes
Participants must not have a history of daily headache, cluster headache, certain migraine subtypes, or other incompatible headache diagnoses
Participants must not be pregnant or nursing
Trial Summary
Conditions the trial is for
Migraine
What the trial is testing?
LY3451838
Could I receive a Placebo?
yes
Enrollment Goal
120
Trial Dates
November 2020 - November 2021
Trial Phase
2
Enter your postal code to find the nearest site
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18-75
Sex
All
Participants must
Participants must have a diagnosis of migraine or chronic migraine
Participants must have a history of migraine headaches at least 1 year prior to screening and that began prior to age 50
Participants must have failed previous migraine preventive medications in the past 10 years due to too little helpfulness or the ability to put up with the medication
Participants must NOT
Participants must not be currently enrolled in or have participated within the last 30 days or within 5 half-lives (whichever is longer) in a clinical trial involving an investigational product. A half-life is the time necessary for half of any drug in the body to be removed by natural processes
Participants must not have a history of daily headache, cluster headache, certain migraine subtypes, or other incompatible headache diagnoses
Participants must not be pregnant or nursing
Trial Summary
Conditions the trial is for
Migraine
What the trial is testing?
LY3451838
Could I receive a Placebo?
yes
Enrollment Goal
120
Trial Dates
November 2020 - November 2021
Trial Phase
2
Not the right fit? Sign up to receive updates on new trials.
Trial Locations
Hide locations not currently recruiting
Enter your postal code to see sites near you
Migraine Resources
